YSEI SHH-SSD Series Multi-Chamber Drug Stability Testing System

Overview

The YSEI SHH-SSD Series Multi-Chamber Drug Stability Testing System is an engineered platform designed specifically for long-term, accelerated, intermediate, and stress-condition stability studies in accordance with ICH Q1 guidelines and regional pharmacopoeial requirements. Each chamber operates as a physically isolated environmental unit, enabling simultaneous execution of multiple ICH-defined protocols—including 25°C/60% RH (long-term), 40°C/75% RH (accelerated), 30°C/65% RH (intermediate), and low-humidity stress testing (e.g., 40°C/20% RH for large-volume parenterals). The system employs precision PID-controlled refrigeration, steam-based humidification with deionized water delivery, and high-stability PT100 sensor arrays calibrated traceably to NIST-certified references. Its architecture supports continuous operation over 12-month cycles with minimal drift—critical for shelf-life determination where data integrity directly impacts regulatory submission validity.

Key Features

• Fully independent chamber control: Each chamber features dedicated temperature/humidity setpoint programming, real-time monitoring, and autonomous alarm logic—eliminating cross-chamber interference during concurrent protocol execution.
• Low-humidity capability: Engineered vapor-pressure differential control enables stable 20% RH maintenance at 40°C, meeting specific requirements for hygroscopic APIs and IV solutions outlined in USP and ICH Q5C.
• Regulatory-grade data recording: Integrated thermal printer produces audit-ready paper records with configurable intervals (1 min to 24 h); all printed outputs include date/time stamps, chamber ID, and measurement units—satisfying ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate) documentation criteria.
• Multi-layer safety architecture: Includes chamber-specific overtemperature cut-off (hardware-independent from main controller), humidifier dry-run detection with auto-shutdown, refrigeration compressor thermal overload protection, and dual-mode notification (local siren + GSM-based SMS alerts for power loss or excursion events).
• Energy-optimized operation: Variable-speed condenser fans, high-efficiency scroll compressors, and insulated double-wall construction reduce average power draw to ≤2.8 kW per chamber under standard 40°C/75% RH load—validated per ISO 15378 Annex A energy consumption test procedures.

Sample Compatibility & Compliance

The SHH-SSD accommodates diverse pharmaceutical dosage forms—including tablets, capsules, injectables, ointments, and lyophilized powders—across ICH-recommended container-closure systems (glass vials, HDPE bottles, blister packs). All chambers are validated per ASTM E2500-18 for qualification of environmental chambers used in GxP environments. System software supports IQ/OQ documentation packages aligned with FDA 21 CFR Part 11 requirements, including electronic signature implementation, audit trail generation, and user access level management (admin/operator/viewer). Full validation support includes pre-executed protocol templates, calibration certificates for all critical sensors, and chamber mapping reports (per ISO 14644-1 Class 8 cleanroom-compatible airflow patterns).

Software & Data Management

While the base configuration operates in standalone mode with local print output, optional Ethernet-enabled firmware enables secure HTTP/HTTPS access to live chamber parameters, historical trend export (CSV/PDF), and remote alarm acknowledgment. Data files are stored in encrypted internal memory with write-protection against unauthorized modification. Software architecture conforms to GAMP 5 Category 3 classification, and all electronic records comply with 21 CFR Part 11 Subpart B requirements—including time-stamped audit trails, role-based permissions, and electronic signature workflows. Backup archives can be exported to external USB drives in timestamped folders, preserving chain-of-custody integrity for regulatory inspections.

Applications

• ICH Q1A(R3)-compliant long-term stability studies (25°C/60% RH) for registration batches and commercial release.
• Accelerated stability assessment (40°C/75% RH) to predict degradation kinetics and establish retest periods.
• Photostability testing per ICH Q1B using optional UV/VIS light modules mounted on standardized photo-sensitive shelving layers.
• Excursion tolerance evaluation for cold-chain deviations or warehouse storage condition failures.
• Comparative formulation screening across multiple candidate products under identical environmental stress profiles.
• Academic research and graduate-level pharmaceutical sciences training in stability science fundamentals and regulatory strategy development.

FAQ

Does the SHH-SSD Series support 21 CFR Part 11 compliance?
Yes—the optional software package includes electronic signatures, audit trails, and role-based access controls fully aligned with FDA 21 CFR Part 11 Subpart B requirements.
Can individual chambers run different ICH protocols simultaneously?
Yes—each chamber is fully autonomous with independent temperature, humidity, and timing control, enabling concurrent execution of long-term, accelerated, and stress-condition studies.
What validation documentation is provided?
YSEI supplies comprehensive IQ/OQ protocol templates, executed reports, sensor calibration certificates (NIST-traceable), and chamber mapping summaries per ISO 14644-1 and ASTM E2500-18.
Is low-humidity testing (e.g., 40°C/20% RH) achievable without external desiccant systems?
Yes—the integrated humidification/dehumidification subsystem maintains 20% RH at 40°C using closed-loop dew-point control, eliminating need for auxiliary desiccant hardware.
How is data integrity ensured during power interruption?
Internal non-volatile memory retains all logged data; GSM SMS alerts notify designated personnel immediately upon outage, and thermal printer resumes logging from last known state post-recovery.